Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000616922 | SCV000727904 | likely benign | not specified | 2018-02-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002064324 | SCV002345520 | likely benign | Noonan syndrome 9 | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358734 | SCV002622499 | likely benign | Cardiovascular phenotype | 2019-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002064324 | SCV002763137 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing |